2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Intermune: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy Interferon Alfacon-1 and Ribavirin - Hepatitis C | Phase 4 | Completed | Beth Israel Medical Center | 40 | 2005-12-01 | 2008-04-17 |
| Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin rosiglitazone - Hepatitis C | Phase 4 | Completed | Brooke Army Medical Center | 34 | 2005-10-01 | 2012-02-14 |
Hepatitis C (2) · Insulin Resistance (1)
Ribavirin (2) · interferon alfacon-1 (2) · Rosiglitazone (1)
United States (2)
Henry C. Bodenheimer, M.D. (1) · Shane Mills, MD (1) · Stephen A Harrison, MD (1)